📌 Key Takeaways
- Topic: Copper Clad Laminate Filler: Silica Types, Dielectric Properties and Selection
- Keywords: silica food additive
- Published: 2026-11-20 02:46:20
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
What Is the Molar Mass of Silicon Dioxide (SiO₂)? Calculation Explained
- Silica in Cosmetics: Functions, Types and Safety
- Talc Powder vs Silica: Differences and Which Filler to Choose
- Xu, B. et al. Immunomodulation‐enhanced nanozyme‐based tumor catalytic therapy. Adv. Mater. 32, 2003563 (2020). Article CAS Google Scholar
- Silica Glidant for Tablets: How It Improves Powder Flow and Typical Dosages
- Wang, X. et al. Recent developments in mesoporous silica nanoparticles for tumor theranostic applications. Curr. Pharm. Des. 28, 151-164 (2022). Piece PubMed Google Scholar
- Is Silica in Cosmetics Safe? Ingredient Safety and Regulatory Status
- Firstly, even though several silica-based nanoformulations have already proceeded to the clinical trial stage and have been shown to be remarkably efficacious and acceptably secure, this is not virtually enough given the tremendous cost researchers have put in upfront. The most crucial consideration driving the successful clinical translation is a comprehensive and systematic toxicity study of MSNs. Despite the fact that a relatively finalize set of toxicity studies on MSNs has been established in the scientific community, a sustained effort is still needed. It is noteworthy that many of the currently designed therapeutic systems for MSNs are disconnected from systematic toxicological evaluations. Some researchers have focused more on the therapeutic impacts, but the feasible MSNs-based nanocomposites constructed on this basis are far from the silica NPs used by another part of the researchers in MSNs toxicology evaluation. In future research, under the premise of guaranteeing the efficacy of MSNs-based nanomedicines, more focus on the toxicological evaluation and long-term biosafety assessment of MSNs will be more useful to promote the possibility of their clinical translation.
Top Fumed Silica Manufacturers: Global Leaders and Emerging Suppliers (2026)
What is silica (SiO₂)?
high purity quartz market Yang, L. et al. Rod-shape MSN@MoS 2 nanoplatform for FL/MSOT/CT imaging-guided photothermal and photodynamic therapy. Theranostics 9, 3992 (2019). Article CAS PubMed Central PubMed Google Scholar
What is the difference between fumed silica and precipitated silica?
colloidal silicon dioxide excipient
What drives silica raw material prices?
silicon dioxide side effects Secondly, it is needed to construct simple but efficient MSNs-based nanoplatforms. The abundant traits of MSNs have led to their vast exploitation as multifunctional nanocarriers, and this may be accompanied by the introduction of two or more elements into MSNs. Although these multifunctional nanoplatforms have proven to be really effective in numerous papers, the complexity of these platforms does not appear to be friendly to the scale-up preparation and clinical translation. On the one hand, it is well known that the laboratory-level synthesis methods of MSN are very different from those used for industrial scale-up production required for clinical screening and use. The reproducibility and batch stability of nanoformulations are always an important component to consider in industrial scale-up production, and in this process, simplifying the production steps is the key to promote the industrial scale-up production. Nonetheless, the complex MSNs-based nanoplatforms call for higher nanoformulation preparation technologies and more stringent storage methods, which often call for more time, effort, and economic investments. On the other hand, the multiple components may introduce more unsafe factors, it appears to be an enormous challenge at this stage to systematically reveal the toxicity mechanisms of these different components when we still do not entirely understand the toxicity mechanisms of MSNs. Hence, it is advocated to slim down the MSNs-based platform as much as possible while meeting the clinical requirements.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.